Xellera Therapeutics provides end-to-end GMP manufacturing solutions for cell and gene therapies, from early development to commercial scale. Our in-house expertise supports CAR-T, VST, iPSC, MSC, NK, and dendritic cell products, ensuring safety, quality, and compliance with global regulatory standards. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/